(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing.
 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Philip Frost, Chairman and CEO of OPKO Health, on the current landscape for the biotech industry, the company product pipeline, and drug pricing. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)

Matt Miller and Paul Sweeney focus on market coverage as Wall Street begins its day, with analysis from Bloomberg Opinion writers, Bloomberg Intelligence analysts, and influential newsmakers.

Share OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)

Sign up to save your podcasts

OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)

OPKO's Frost: BioReference Was a Tremendous Acquisition (Audio)